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In this work, the presence of selected emerging contaminants has been investigated in two reservoirs, La 25	
Fe (LF) and Riogrande (RG), which supply water to two drinking water treatment plants (DWTPs) of 26	
Medellin, one of the most populated cities of Colombia.  An analytical method based on solid phase 27	
extraction (SPE) of the sample followed by measurement by liquid chromatography coupled to tandem 28	
mass spectrometry (LC-MS/MS) was developed and validated for this purpose. Five monitoring 29	
campaigns were performed in each reservoir, collecting samples from 7 sites (LF) and 10 sites (RG) at 30	
three different depths of the water column. In addition, water samples entering in the DWTPs and treated 31	
water samples from these plans were also analyzed for the selected compounds. Data from this work 32	
showed that parabens, UV filters and the pharmaceutical ibuprofen were commonly present in most of the 33	
reservoir samples. Thus, methyl paraben was detected in around 90% of the samples collected, while 34	
ibuprofen was found in around 60% of the samples. Water samples feeding the DWTPs also contained 35	
these two compounds, as well as benzophenone at low concentrations, which was in general agreement 36	
with the results from the reservoir samples. After treatment in the DWTPs these three compounds were 37	
still present in the samples although at low concentrations (<40ng/L), which evidenced that they were not 38	
completely removed after the conventional treatment applied. The potential effects of the presence of 39	
these compounds at the ppt levels in drinking water are still unknown. Further research is needed to 40	
evaluate the effect of chronic exposure to these compounds via consumption of drinking water. 41	
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Reservoirs are artificial lakes formed by the accumulation of water from rivers, creeks, streams and other 53	
natural sources, which are subject to the influence of its tributaries and associated watersheds. Storage in 54	
a reservoir increases the availability of water for various purposes, such as the generation of electric 55	
power, irrigation of crops, industrial use and supply of drinking water for human consumption, among 56	
others (Martinez-Zapata, 2011). Specifically, the quality of drinking water is conditioned by the water of 57	
the reservoirs that feed the treatment plants producing drinking water. These systems are exposed to 58	
numerous natural and anthropogenic factors (Uhlmann et al., 2011). The impact of human activities on 59	
the aquatic environment has increased due to the growth in population and industrialization, which has 60	
intensified discharges from domestic, industrial and agricultural wastewater, the main sources of 61	
pollution. 62	
Nowadays, there is a general concern on the presence of emerging contaminants in the water 63	
environment. Pharmaceuticals and personal care products (PPCPs) are of particular concern due to their 64	
wide use and their occurrence in treated wastewater and surface waters (Gracia-Lor et al., 2012a, 2012b). 65	
These compounds are not regulated yet in water legislation and can be harmful for the aquatic ecosystem, 66	
and become a hazard for human public health (Barceló and Petrovic, 2007; Daughton, 2004; Farré et al., 67	
2008). These compounds are present in urban wastewater, but are not efficiently removed in the 68	
wastewater treatment plants (WWTP) that apply conventional treatments (Gracia-Lor et al., 2012b; Gros 69	
et al., 2010; Jelic et al., 2011; Lacey et al., 2008). In addition to the inefficient removal in WWTPs, some 70	
of them are also persistent and can be bioaccumulated in living organisms (Daughton and Ternes, 1999; 71	
Yang et al., 2014; Zeng, 2015). Within the group of PPCPs, many different families of compounds can be 72	
included, as those used in medicine, veterinary or agriculture, cosmetics, UV filters, fragrances, and even 73	
additives in food (Farré et al., 2008; Martinez Bueno et al., 2016). Oppositely to most priority pollutants 74	
included in the current legislation, which have high toxicity and/or persistence in the environment, PPCPs 75	
do not commonly have these characteristics, but are continuously released in the aquatic ecosystems (via 76	
urban wastewater), where non short-term detectable effects may occur (Muñoz et al., 2008), although 77	
long-term effects are still unknown. The fact that many PPCPs are not efficiently removed in the WWTPs 78	
means that these compounds can easily reach surface water (Dai et al., 2015; Kasprzyk-Hordern et al., 79	
2008; Liu et al., 2015; Matamoros et al., 2012) and even drinking water (Boyd et al., 2003; Carmona et 80	
al., 2014; Kumar and Xagoraraki, 2010; Sodré et al., 2010; Vulliet et al., 2011). 81	
Colombia has many aquatic ecosystems providing water for human and industrial consumption. 82	
Specifically, Antioquia province is very rich in hydric resources, which are used for energy and drinking 83	
water production. This is the case of the reservoirs La Fe (LF) and Riogrande (RG), which are the source 84	
of water supply of the two drinking water treatments plants (DWTPs) of Medellin: La Ayurá (LA) and 85	
Manantiales (MA). Although these reservoirs are located in low population areas, they can receive the 86	
impact of wastewater, both from urban and agricultural origin (Martinez and Peñuela, 2013). Therefore, it 87	
becomes necessary to investigate the occurrence of emerging contaminants to have a better knowledge on 88	
the presence of these compounds in the reservoirs, and eventually in drinking water.  89	
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The objective of this work was to investigate the presence of selected PPCPs in water samples from these 90	
two reservoirs, and in samples entering in two DWTPs that use water from these reservoirs, as well as in 91	
treated drinking water samples. To this aim, an analytical method based on the use of liquid 92	
chromatography coupled to tandem mass spectrometry (LC-MS/MS) was developed and validated for the 93	
determination of ibuprofen (IBU), diclofenac (DIC), clofibric acid (ACF), carbamazepin (CBZ), 94	
benzophenone (BZP), benzophenone-3 (BZP-3), methylparaben (MePB), ethylparaben (EtPB) and 95	
buthylparaben (BuPB) in surface water. A solid phase extraction (SPE) was applied to water samples, 96	
which allowed to obtain a pre-concentration factor of 200. Five monitoring campaigns were performed in 97	
each reservoir, collecting waters from seven sites (LF reservoir) and 10 sites (RG reservoir) at three 98	
different water column depths: sub-surface, photic zone limit, and bottom. In addition, samples from the 99	
entrance and the exit of the DWTPs were also analysed for these compounds. Considering the general 100	
lack of data on PPCPs in Colombian surface waters, particularly in the Medellin area, this paper was 101	
conceived as a preliminary study to investigate the presence of some of the most consumed/used 102	
compounds in the area under study. Further studies will be required, including more PPCPs and 103	
metabolites/transformation products (TPs), to have a better knowledge of the issue treated, and to suggest 104	
subsequent actions to protect the aquatic environment, if needed.  105	
 106	
2. Experimental 107	
2.1 Regents and chemicals 108	
Reference standards of ibuprofen (99%), diclofenac (99%), clofibric acid (99.5%), and carbamazepin 109	
(99.5%) were from Dr. Ehrenstorfer (Germany); benzophenone (99.4%), methylparaben (99.5%), 110	
ethylparaben (99.5%) and buthylparaben (99.5%) from Chemservice (West Chester, USA); and 111	
benzophenone-3 (100%) from Accustandard (New Haven, USA). Isotope-labelled internal standards 112	
(ILIS) of ibuprofen-d3 (IBU-d3) was from Toronto Research Chemicals TRC (Toronto-Ontario, Canada), 113	
and ethylparaben-d4 (EtPB-d4) from CDN Isotopes (Quebec, Canada). LC-MS grade methanol was from 114	
Merck (New Jersey, USA) and acetonitrile from Honeywell, B. & J. Brand (USA).  HPLC-grade water 115	
was obtained by purifying demineralized water in a Milli-Q Gradient A10 (Millipore, Bedford, MA, 116	
USA).  Formic acid 98-100% was from Merck (New Jersey, USA). 117	
Individual stock solutions of 1000 mg/L of both, reference standards and ILIS, were prepared by 118	
dissolving 10 mg in 10ml MeOH. From these individual solutions, a mix solution of 100 mg/L containing 119	
the PPCPs was prepared by dilution in MeOH. Working mix solutions of 10, 1 and 0.1 mg/L PPCPs were 120	
prepared in MeOH from the 100 mg/L mix solution. A mix solution of ILIS of 2 mg/L IBU-d3 and 10 121	
mg/L EtPB-d4 was also prepared in MEOH from a 100 mg/L solution.  122	
Sample extraction was made by solid phase extraction (SPE) using Oasis HLB cartridges (60 mg) from 123	
Waters Corp. (Milford, MA, USA). 124	
 125	
2.2 Liquid chromatography 126	
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An Acquity UPLC system (Waters Corp., Milford, MA, USA) was used, equipped with a quaternary 127	
solvent manager and a sample manager. Chromatographic separation was performed using an Acquity 128	
UPLC BEH C18 column,, 2.1 x 50 mm, 1.7 µm, (Waters) at a flow rate of 0.3mL/min. The column was 129	
kept at 40ºC and the sample manager was maintained at 5ºC. The mobile phase consisted of water with a 130	
0.01% HCOOH/methanol gradient. The methanol percentage was changed linearly as follows: 0 min, 131	
10%; 9 min, 90%; 9.5 min, 90%; 10.5 min, 100%; 10.6 min, 100%; 11.7 min, 10%. Analysis run time 132	
was 12.7 min. The sample extract injection was 20 µL. 133	
 134	
2.3 Mass Spectrometry 135	
An Acquity UPLC system was coupled to a TQD (triple quadrupole) mass spectrometer with an ortho-136	
gonal Z-spray-electrospray (ESI) (Waters Corp., Milford, MA, USA). Both the drying gas and the 137	
nebulising gas was nitrogen generated from pressurized air in a N2 LC–MS nitrogen generator (Peak 138	
Scientific, EE. UU). The cone gas and the desolvation gas flows were set at 80 and 800L/h, respectively. 139	
For operation in MS/MS mode, the collision gas was Argon 99.995% at 2x10-3 mbar in a T-Wave 140	
collision cell. Capillary voltages of -2.8 kV (negative ionization mode) and 3.0 kV (positive ionization 141	
mode) were applied. The interface temperature was set to 450 ºC and the source temperature to 150 ºC. 142	
Dwell times of 0.1 s were selected. Masslynx 4.1 (Micromass, Manchester, UK) software was used to 143	
process the quantitative data. 144	
The studied compounds were measured in ESI positive and/or ESI negative mode during the same 145	
injection acquiring two MS/MS transitions per compound. The acquisition of two transitions, of which 146	
the most sensitive was used for quantification (Q) and the other was used for confirmation (q), ensured 147	
the appropriate identification of the analytes in the samples. Only one transition was available for IBU 148	
205>161 (Q) due to the poor fragmentation of this compound under the conditions applied. The 149	
transitions selected, and the optimized conditions of cone voltage and collision energy are shown in 150	
Table 1. 151	
 152	
2.4 Sample procedure 153	
Water samples were firstly centrifuged (Boeco Centrifuge U-320R, Germany) for 10 min at 4500 rpm to 154	
separate particulate matter (filtration was discarded to avoid potential losses in the filter). Then, SPE was 155	
applied within 48h after samples collection. When this was not possible, the centrifuged samples were 156	
stored in the freezer at – 20ºC (Revco-Thermo Scientific). Conditioning of the SPE cartridges was made 157	
with 3 mL MeOH and 3 mL ultrapure water. After conditioning, 200 mL of the water sample (adding 50 158	
µL of the mix ILIS solution (2 mg/L IBU-d3, 10 mg/L EtPB-d4)) were loaded into the SPE cartridge at a 159	
flow of 1-2 mL/min. The cartridges were air dried, and analytes were eluted with 5 mL MeOH. The eluate 160	
was evaporated under a gentle nitrogen stream and the residue was reconstituted 1 mL MeOH-H2O 161	
(10:90, v/v). Finally, 20 µL of the extract was injected into the UHPLC-MS/MS system under conditions 162	
indicated in Table 1.  163	
6	
	
Quantification was made with standards prepared in solvent, using relative responses analyte/ILIS, or 164	
absolute responses, depending on whether ILIS was used for correction or not. All compounds measured 165	
in negative mode were quantified using ILIS for matrix effects correction. Thus, parabens (MePB, EtPB 166	
and BuPB) were quantified using EtPB-d4, while IBU was quantified using IBU-d3. After a previous 167	
study on the best ILIS to be used for matrix effects correction, EtPB-d4 was selected for quantification of 168	
DIC and ACF. The three compounds measured in positive mode (CBZ, BZP, BZP-3) were quantified by 169	
external calibration using standards in solvent without ILIS due to the unavailability of appropriate ILIS 170	
in our laboratory. In any case, our data did not show relevant matrix effects for these compounds in the 171	
samples tested.  172	
 173	
2.5 Study Area and samples collection 174	
The present study was carried out in two reservoirs (RG and LF)  that are used for drinking water supply 175	
to the city of Medellin after the water being treated in two DWTPs. Samples were taken from three 176	
depths: the subsurface, photic zone limit and reservoir bottom in order to evaluate the presence of 177	
pollutants along the overall water column. Ten sampling locations were selected in reservoir RG (Fig 1) 178	
and seven locations in reservoir LF (Fig 2). Additionally, water samples were also collected in each 179	
tributary at locations before the entry to the each reservoir (Figure 1, numbers 12, 15, 17 and 19; Figure 2, 180	
numbers 8, 9, 10 and 11).The samples were collected using a Schindler bottle. An aliquot of 200 mL of 181	
each sample was transferred to amber glass bottles that were previously cleaned and heated to 450 °C for 182	
8 h to remove any presence of organic matter. Then, they were transported to the laboratory under cooled 183	
conditions (4°C).  184	
Influent and effluent samples from the two DWTPs (Manantiales (MA), fed with water from reservoir 185	
RG; and La Ayurá (LA) fed with water from reservoir LF) consisted on 24-h composite samples. The 186	
effluent samples (i.e. drinking water supplied to Medellin) were amended with sodium thiosulfate 187	
immediately after collection to eliminate residual chlorine (Martinez and Peñuela, 2013). 188	
The monitoring plan for reservoirs, tributary rivers and DWTPs is summarised in Table 1SI 189	
(Supplementary Information). 190	
 191	
3. Results and discussion 192	
The selection of the compounds under study was made based on the main human activities in the area and 193	
on previous data reported in a preliminary study performed on the presence of PPCPs (Gracia-Lor et al., 194	
2012a). The area around reservoir LF and their tributaries has experimented an increased urbanization 195	
process and recreational events, including the touristic park Los Salados. Reservoir RG is more affected 196	
by agricultural activities, and several farms (mainly cattle and pigs) are located in the nearby areas. 197	
Despite the presumably presence of pesticides, because of the agricultural activities, we focused our study 198	
on pharmaceuticals. Thus, four compounds were selected such as ibuprofen and diclofenac, which are 199	
analgesic/anti-inflammatory drugs commonly consumed around the world (Mendez-Arriaga et al., 2010; 200	
Scheurell et al., 2009) and specifically in Colombia; they are easily accessible for consumers and are 201	
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included in the Colombian national strategy for Human Health. Carbamazepine is used for epilepsy 202	
treatment and is frequently found in natural and waste waters (Bade et al., 2015; Hernández et al., 2015; 203	
Sun et al., 2013); and clofibric acid, which is used to decrease cholesterol and triglicerids levels in blood 204	
(Saravanan et al., 2011).  205	
A preliminary study made by our own group in collaboration with the University Jaume I of Castellon 206	
(Gracia-Lor et al., 2012a) revealed the presence of several personal care products in waters from these 207	
two reservoirs, specifically benzophenones, commonly used in UV filters and other products of wide use. 208	
Benzophenone and benzophenone-3 were identified in several of the samples. Parabens, used as 209	
preservatives in cosmetics and even as additives in food, were also found in the water samples (methyl 210	
paraben, ethyl paraben, and buthyl paraben).  211	
Altogether, 9 PPCPs were selected for this study, 4 of them being drugs of wide consumption and/or 212	
frequent detection in waters, and 5 being personal care products.  213	
 214	
3.1 Analytical Methodology 215	
The method linearity was studied in the range 1–100 µg/L. Calibration curves showed satisfactory 216	
correlation coefficients (greater than 0.99) and residuals were lower than 30%. The method accuracy was 217	
evaluated in surface water spiked (n=5) at three concentration levels (0.05, 0.25 and 0.45 µg/L). The 218	
results were satisfactory in terms of precision, expressed as relative standard deviation (RSD) (lower than 219	
20%) and accuracy, expressed as percentage recovery (between 70 and 120%) for the analysis of PPCPs 220	
under study (Table 2). 221	
Limits of detection (LOD) were calculated as a function of the standard deviation for a 99% confidence 222	
level (Brown and Berthouex, 2002; Martinez-Zapata, 2011), (n=7) in a sample spiked at 0.25µg/L. Limits 223	
of quantification (LOQ) were taken as 3.3 x LOD (Table 2). 224	
Confirmation of positive findings was carried out by calculating the peak area ratios between the 225	
quantification (Q) and confirmation (q) transition. The finding was considered as true positive when the 226	
experimental ion-ratio was within the tolerance range (Gracia-Lor et al., 2012b), and the retention time in 227	
the sample within ±2.5% when compared with a reference standard (see Table 1 for Q/q ratios empirically 228	
obtained for reference standards). 229	
A problem occurred in the determination of BZP, which seemed to be related to a contamination of the 230	
LC-MS/MS system used for analyses. For this reason, data were available only for samples collected until 231	
October 2012. From then on, although a peak clearly differentiated from the blank was observed for 232	
several of the samples (suggesting that the sample was positive for this compound), we could not 233	
accurately quantified this analyte. 234	
 235	
3.2 Reservoir samples 236	
The validated method was applied to water samples collected from reservoirs and the drinking water 237	
treatment plants.  In every sequence of analysis (around 20 samples), a calibration curve was injected. 238	
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Quality control (QC) samples (i.e blank samples fortified at 0.25 µg/L with the selected PPCPs) were also 239	
analyzed in every sequence in order to test the robustness and applicability of the method to the samples 240	
under study. Confirmation of positive findings was based on the agreement of Q/q ratios and 241	
chromatographic retention times between samples and reference standards (see Analytical Methodology).  242	
 243	
3.2.1 Reservoir Rio Grande (RG) 244	
The highest percentage of positive samples corresponded to BZP, MePB and IBU, which were detected in 
245	
many of the samples analysed (Table 3). In relation to DIC, it was only found in the samples from April 
246	
(11% positives) and November (3% positives), always at levels below LOQ.  BZP-3 was only detected in 
247	
samples from April with an average concentration of 238 ng/L, and EtPB was scarcely found, with only 
248	
4% of positives in the monitoring of April (all < LOQ).  BuPB, CFA and CBZ were not detected in any of 
249	
the samples from this reservoir. In general, not a clear trend was observed in the concentrations of these 
250	
compounds as a function of the sampling date.  
251	
Concentrations of MePB, and mainly IBU, seemed to slightly increase along the depth of the water 252	
column in most of sampling stations (Fig 1SI), which would imply that these compounds are sorbed onto 253	
the sediments (IBU, Log Kow 3,97; MePB, Log Kow 4,5) (Fatta-Kassinos et al., 2013; Vergili, 2013).  In 254	
addition, humic material tends to accumulate into the bottom, which might facilitate the complexation 255	
with the contaminants (Hincapie - Upegui., 2014) that would be associated to the sediments and/or to the 256	
bottom of the water column.  257	
We did not observe a clear trend in the spatial distribution of MePB in the different stations monitored in 
258	
this reservoir, although a notable increase in concentration in the bottom samples was found in stations 7 
259	
and 8 in October 2012 (Fig 1SI), a fact that could not be easily explainable. For IBU, the trend of the 
260	
concentrations was more uniform in sub-surface, photic limit zone and bottom samples. In general, 
261	
concentrations in station 1, which was near the tributary Rio Chico (number 12) were a bit higher, and 
262	
then decreased along stations 2 and 3 (see map shown in Figure 1). However, the possible influence of the 
263	
other tributaries was not so evident in those stations that might be more affected, i.e. stations 6, 4 and 10.   
264	
Additionally to samples from reservoir RG, water samples were also collected in each tributary at 
265	
locations just before the entry to the reservoir (Fig 1) in order to evaluate whether they were the main 
266	
source of pollution of the reservoir. Concentration data found in tributaries 12, 15, 17 and 19, in the two 
267	
monitoring campaigns, are shown in Table 4. 
268	
In the tributaries, similarly to the reservoir samples, the predominant compounds were BZP, MePB and 269	
IBU, although BZP-3 was also found at notable concentrations in samples collected in April. The 270	
presence of IBU in tributary 12 (Rio Chico) in both monitoring campaigns may explain the presence of 271	
this compound in reservoir samples of station 1, located near the entry of this tributary. From sampling 272	
station 1 onwards, IBU concentrations slightly decreased along the distance (stations 2 and 3).  273	
BZP and MePB were present in all tributaries, which might explain the presence of these compounds in 274	
the reservoir. Similarly to the results found in the reservoir, BZP-3 was only found in the samples 275	
collected in April 2012. Although no relevant differences were observed in general between the 276	
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tributaries in terms of analyte concentrations, the tributary15 was the only one where the three parabens 277	
included in this study, BuPB, EtPB and MePB, were found, with the latter being present at relatively high 278	
concentrations (242 ng/L).  279	
 280	
3.2.2 Reservoir La Fe (LF) 281	
In general, the behaviour and concentrations found in this reservoir were similar to those found in 282	
reservoir RG. The higher concentrations were commonly observed in the first monitoring, June 2012, 283	
although no significant variations were observed along the different periods of the year.  284	
The compounds most detected in this reservoir were again BZP, MePB and IBU, although other parabens 285	
(BuPB, EtPB) were also found in several of the samples at detectable concentrations (mostly below 60 286	
ng/L) (Table 5). 287	
Additionally, the most important tributaries (numbers 8, 9, 10, 11; see map in Figure 2) were also 288	
monitored in October and December 2012, and February 2013 (Table 6). The PPCPs concentrations in 289	
these tributaries were lower than tributaries from the other reservoir (see Table 4), as only IBU and MePB 290	
were found at detectable concentrations (no data available for BZP). In all positives, concentrations were 291	
below 80 ng/L. This fact illustrates that, at least for the compounds selected in this study, the tributaries 292	
seemed not be an important source of pollution in the reservoir. 293	
No clear trends were observed in the spatial distribution of the compounds in this reservoir (Fig 2SI) and, 294	
as stated above, the influence of the tributaries was not perceived.  295	
The presence of PPCPs in urban wastewater has been widely reported in the scientific literature, at 296	
concentrations that are sometimes well above 1000 ng/L. High levels can be found  even in effluent 297	
wastewater, as many of these compounds are not efficiently removed in WWTPs (Alidina et al., 2014; 298	
Anumol and Snyder, 2015; Carmona et al., 2014; Gracia-Lor et al., 2012b; Gros et al., 2010; Jelic et al., 299	
2011; Lacey et al., 2008; Liu and Wong, 2013). This fact explains that a notable number of PPCPs are 300	
present in surface water, including the compounds studied in this work. 301	
Specifically, MePB has been found in wide concentrations ranges, with average values near those 302	
reported in our work for reservoir samples (around 100 ng/L) (Carmona et al., 2014; Kasprzyk-Hordern et 303	
al., 2008; Peng et al., 2008). Ibuprofen is one of the compounds more frequently detected in surface water 304	
around the world (Fernández et al., 2010; Kasprzyk-Hordern et al., 2008; Lindholm-Lehto et al., 2016; 305	
Liu et al., 2015; Liu and Wong, 2013; Matamoros et al., 2012; Peng et al., 2008; Tran et al., 2014; Wang 306	
et al., 2010). Concentrations reported are commonly higher than those found in reservoirs RG and LF. 307	
Thus, values up to 2,700 and 1,800 ng/L have been reported for IBU in Spain and Vietnam, respectively 308	
(Fernández et al., 2010; Tran et al., 2014), which are clearly higher than in our work (≤60 ng/L). 309	
Less data exist on BZP levels in surface water, and most studies are focused on BZP-3 (Kim and Choi, 310	
2014). The presence of BZP has been reported in surface water from California, with maximum 311	
concentrations of 5.1 ng/L (Alvarez et al., 2014). Although not detected in our study, BZP-3 is commonly 312	
found in surface water, at levels up to 125 ng/L (Kim and Choi, 2014). 313	
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In the present work, several compounds selected (DIC, CBZ, CFA, EtPB, BuPB) were not detected in the 314	
reservoir samples. However, their presence in surface water has been reported in several previous studies. 315	
For example, CBZ has been found at low concentrations in Finland (1.2 ng/L) (Lindholm-Lehto et al., 316	
2016), and at much higher concentrations in Vietnam (5,110 ng/L) (Tran et al., 2014). DIC is commonly 317	
reported in surface water, at concentrations from 10 ng/L, in Switzerland, to 700 or 800 ng/L, in China or 318	
Spain (Fernández et al., 2010; Wang et al., 2010). Parabens (Carmona et al., 2014; Esteban et al., 2014; 319	
Kasprzyk-Hordern et al., 2008) and CFA are usually present at low levels in fresh waters (around or 320	
below 50 ng/L) (Gros et al., 2006; Hernando et al., 2006; Kasprzyk-Hordern et al., 2008; Öllers et al., 321	
2001; Wang et al., 2010). 322	
Data from above show that the compounds selected in our study are commonly present in fresh water 323	
from many countries around the world. In general, the levels reported in our work for reservoir water and 324	
tributaries samples are lower than reported in the majority of studies performed in other countries. 325	
However, more data and extensive monitoring programs would be necessary to confirm this fact. 326	
 327	
3.3. Drinking water treatment plant samples 328	
Four monitoring campaigns were carried out in two DWTPs: Los Manatiales (MA) and La Ayurá (Table 329	
1SI). The DWTP of MA receives water from the reservoir RG, and the catchment is located at station 4 330	
(Fig 1), while DWTP of LA receives water from reservoir LF, with the catchment being located at station 331	
3 (Fig 2).  332	
The results obtained for analyses of influent water (water from the reservoir collected in the catchment 333	
station) and in effluent water (treated water already used for drinking water supply) are shown in Table 7. 334	
The compounds IBU, MePB and BZP were the most frequently detected, similarly to the reservoir and 335	
tributary samples. These were present in both influent and treated water of the two drinking water 336	
treatment plants. The concentrations found in the influents were in general consistent with those of the 337	
reservoir samples, specifically from stations 4 (RG) and 3 (LF), where the catchments are located. This 338	
supports the observation that these compounds are present in the reservoir water and enter in the DWTP. 339	
In addition to the three major contaminants, BZP-3, DIC and BuPB were occasionally detected in the 340	
influent of MA, although at concentrations < 30 ng/L. The first two compounds were also occasionally 341	
found in the RG reservoir samples in some monitoring campaigns, but BuPB was never found in the 342	
reservoir; a fact that needs further research for confirmation. A similar situation was observed in influent 343	
samples from LA, where in addition to the three major compounds, BZP-3 and DIC were occasionally 344	
detected although at low concentrations (< 30 ng/L), while they were not detected in the LF reservoir 345	
samples. 346	
The comparison of data from influent and effluent samples from DWTPs showed that PPCPs present in 347	
the catchment were not completely removed in the conventional treatment applied. For example, the 348	
removal efficiency for BZP, MePB and IBU was found to be between 30-60% (BZP), 20-60% (MePB), 349	
and 0-50% (IBU) in MA DWTP, while it was much lower in the LA DWTP (Table 7). These results are 350	
in agreement with previous data reported on drinking water treatment (de Jesus Gaffney et al., 2014; 351	
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Padhye et al., 2014). Both DWTPs apply conventional treatments, based on coagulation, flocculation, 352	
sedimentation and filtration, which would be expected to efficiently remove hydrophobic compounds of 353	
high molecular weight, less soluble in water, but not necessarily emerging contaminants that are more 354	
polar in nature. For this reason, polar emerging compounds, as the majority of PPCPs, when present in 355	
water at low concentrations, would remain in the aqueous phase and would not be removed along the 356	
coagulation-flocculation process, leading to low removal efficiencies in the treatment plant (Rodríguez-357	
Paniagua, 2015). 358	
In addition, both DWTPs also apply chlorination, a process that allow to eliminate the great majority of 359	
organic compounds, although not all of them. It has been reported that the use of oxidizing agents is 360	
appropriate for removal of emerging contaminants in drinking water treatment (Huber et al., 2005), 361	
however, the kinetic of the process can be slow and other by-products (in some occasions of unknown 362	
effects on human health) can be formed (Rodríguez-Paniagua, 2015). According to our data, it seems that 363	
the low chlorine doses used in the DWTPs were not sufficient to completely remove some PPCPs. 364	
Therefore, it would be necessary to improve the treatment in order to remove trace levels of PPCPs in 365	
drinking water, for example, using higher doses of chlorine or implementing tertiary treatments, such as 366	
advanced oxidation systems, that are more efficient to this aim. 367	
In any case, the levels found in drinking water (effluent already treated and used for drinking water 368	
supply) were always below 50 ng/L, with the only exception of MePB in the sample collected in MA in 369	
September 2012 (80 ng/L) (Table 7). Although concentrations were below 0.1 µg/L (the reference value 370	
used by default for pesticide residues in drinking water), no sufficient data exist to assess the potential 371	
harmful effects on human health. Therefore, more research is required in the near future on this issue. 372	
Confirmation of positive findings was based on the agreement of Q/q ratios and chromatographic 373	
retention times between samples and reference standards (see Analytical Methodology). Similarly to the 374	
reservoir and tributary samples, QCs (drinking water samples fortified at 0.25 µg/L with the selected 375	
PPCPs) were analyzed in every sequence in order to test the robustness and applicability of the method. 376	
As illustrative example, Fig 3 shows the LC-MS/MS chromatograms for an effluent sample from 377	
Manantiales DWTP, where BZP and MePB were found and their identity confirmed by Rt and ion/ratio 378	
agreement with the reference standard. 379	
Our findings are in the line of previous data reported on occurrence of PPCPs in drinking water around 380	
the world. It is not rare to find some of these compounds in drinking water at the few ng/L level. 381	
Specifically, the compounds selected in our work have been found in drinking waters, as summarized in a 382	
recent review (Bialk-Bielinska et al., 2016), where maximal concentrations reported for diclofenac, 383	
carbamazepine and ibuprofen are given. Thus, IBU was frequently reported in DW from USA, Japan, 384	
China, Portugal and Spain, typically at concentrations between 10-30 ng/L. DIC was also reported in DW 385	
from Japan and China at maximal concentrations of 16 and 10 ng/L, respectively; and also in Spain, at 386	
average concentrations of 18 ng/L (Bialk-Bielinska et al., 2016; Carmona et al., 2014). However, it seems 387	
that this compound was not present in finished water, after disinfection (Cai et al., 2014). Contrarily to 388	
our work, where CBZ was not detected in DW, this compound was frequently found, at maximal 389	
concentrations between 2 and 5.6 ng/L, in DW from Canada, Spain and USA, and between 14 and 35 390	
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ng/L in Portugal, Japan and China. CBZ was also found in finished water subjected to disinfection in all 391	
the five sample analysed from Beijing, China, at concentrations between 0.4 and 1.2 ng/L (Cai et al., 392	
2014).  393	
There are very few data on the presence of parabens in drinking water (Haman et al., 2015). In the United 394	
States, MePB was never detected in a study on drinking water sources and treated drinking water (Loraine 395	
and Pettigrove, 2006). However, in Spain MePB (17 and 40 ng/L) was quantified in tap water (Blanco et 396	
al., 2009; Casas Ferreira et al., 2011). These two studies did not observe any EtPB, PrPB or BuPB. 397	
Another recent Spanish study (Carmona et al., 2014) demonstrated the presence of MePB (12 ng/L), PrPB 398	
(9 ng/L) and BuPB (28 ng/L), but not EtPB. In our work, MePB was also found at concentrations 399	
between 21 and 80 ng/L, while EtPB was not detected, and BuPB was only once at 7 ng/L. 400	
Although the presence of the UV filters benzophenones in effluent wastewater and surface water has been 401	
reported, there are very little studies on drinking water. BZP-4 was found in DW from Galicia, Spain, at 402	
maximum concentrations of 62 ng/L (Rodil et al., 2012) , close to the levels reported in our work (around 403	
40 ng/L). Benzophenone was also reported in an early study made in the United States in drinking water 404	
at concentrations above 100 ng/L (Loraine and Pettigrove, 2006). 405	
The regulations on PPCPs in drinking water are still insufficient around the world, and no maximum 406	
levels have been established in most countries yet. Taking as a reference the maximum level allowed for 407	
pesticides in drinking water according to the European Directive (European Union, 1998) (0.1 µg/L), the 408	
concentrations found for the PPCPs under study were lower than this value. However, it is not possible to 409	
fully evaluate the potential hazard of PPCPs at these low levels for public health due to the lack of long-410	
term exposition risk data for these compounds. However, the application of the precautionary principle 411	
seems necessary, and measurements should be taken to efficiently remove PPCPs in the DWTPs. 412	
The research presented in this paper can be considered as a preliminary study that reveals the occurrence 413	
of selected PPCPs in reservoirs of Medellin, and their potential presence in drinking water produced from 414	
these reservoirs. Subsequent actions will be needed in the near future, including ambitious monitoring 415	
programs where the number of compounds should be notably increased. In addition, selected 416	
metabolites/TPs should be also included in the monitoring, because most pharmaceuticals are excreted as 417	
metabolites more than as the parent compound, and can also suffer degradation/transformation processes 418	
in the aquatic environment. Therefore, the occurrence of TPs can be more frequent than that of the parent 419	
compounds (Boix et al., 2016; Ibáñez et al., 2016).  420	
 421	
4. Conclusions 422	
In this work, several PPCPs have been monitored in two important reservoirs near Medellin, as well as in 423	
the main tributaries of these reservoirs. Our data showed that some preservatives (parabens, mainly 424	
MePB), UV-filters, as BZPs and BZP-3, and the pharmaceutical IBU were present in most of the samples 425	
analysed. The presence of these compounds in the tributaries may explain their detection in the reservoir 426	
water samples, although other sources of pollution should not be discarded. 427	
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As reservoir water is used for catchment of drinking water treatment plants, these compounds (mainly 428	
MePB, IBU and BZP) were also present in the influent of the DWTPs. Analysis of treated water showed 429	
that these compounds were not completely removed after the conventional treatments applied for drink 430	
water supply (coagulation, flocculation, sedimentation, filtration, and subsequent disinfection by 431	
chlorination). This reveals that conventional treatments, which had been designed to remove the great 432	
majority of organic matter, are not efficient enough to remove polar contaminants present at low 433	
concentrations in the influent water, as occurs for most of emerging contaminants.  434	
The PPCPs concentrations found in drinking water were all below 80 ng/L (e.g. below 0.1 µg/L, which is 435	
the maximum concentration allowed for pesticides –a group of contaminants subjected to strict regulation 436	
in drinking water). Insufficient information exists to assess the potential harmful effects of these low 437	
levels on human health. It seems necessary the application of the precautionary principle until more data 438	
are available to properly evaluate the risks for the population. More research is required in the near future 439	
considering a higher number of PPCPs, including the most consumed by population, because synergic 440	
effects have to be taken into account. The presence of metabolites and transformation products is another 441	
issue of concern, as many pharmaceuticals are hardly excreted as parent compound; therefore, the 442	
presence of some parent pharmaceuticals may only be the visible part of the iceberg of this complex and 443	
of current concern issue. 444	
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 452	
SUPPLEMENTARY MATERIAL 453	
In this section, two figures are included, showing the distribution of IBU and MePB in reservoir RG 454	
(Figure 1SI) and in reservoir LF (Figure 2SI) water collected at three depths for different sampling 455	
stations and monitoring dates. Also three tables, 1SI: Monitoring plan for reservoirs, tributary rivers and 456	
DWTPs, 2SI: Concentrations (ng/L) found for BZP, MePB and IBU in samples from reservoir RG, 3SI: 457	
Concentrations (ng/L) found for BZP, MePB and IBU in samples from reservoir LF, are included to 458	
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Table 1. MS conditions for the LC-MS/MS measurement of the compounds under study.  634	
	635	
 636	
* Average ion intensity ratios for calibration standards (7 calibration points), and relative standard 637	






















Energy (ev) Q/q1 * 
Benzophenone 
(BZP) + 182.9>104.9 34 182.9>76.9 14 3.39 (3.5) 
Benzophenone-3 
(BZP-3) + 228.9>150.9 42 228.9>104.9 18 1.18 (5.1) 
Butylparaben 
(BuPB) - 193.1>92.0 42 192.9 >136.1 24 2.15 (3.6) 
Carbamazepine 
(CBZ) + 237.1>194.1 25 237.1>165.2 20 42.6 (4.2) 
Clofibric Acid 
(CFA) - 215.2>129.0 20 213.7>127.0 15 5.03 (7.0) 
Diclofenac  
(DIC) - 294.1>250.0 20 295.8>252.0 10 1.33 (3.2) 
Ethylparaben 
(EtPB) - 165.1>92.0 36 164.8>136.7 20 1.78 (9.5) 
Ibuprofen  
(IBU) - 205.1>161.1 20 - 5 - 
Methylparaben 
(MePB) - 151.0>92.0 34 150.8>135.9 20 1.67 (4.3) 
Ibuprofen-D3 - 208.1>164.0 20 - 10 - 
Ethylparaben-D4 - 169.2>96.1 30 - 25 - 
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Table 2. Analytical characteristics of the method: average recovery (%) and precision (expressed as % RSD, in brackets) for three fortification levels (five replicates 652	










   Reservoir  LF Reservoir  RG Ultra Pure water 




















BZP 7.47 2.8 96 (1) 76 (9) 75 (7) 88 (4) 71 (10 73 (8) 69 (6) 75 (17) 80(11) 
BZP-3 8.24 2.3 115 (17) 78 (10) 90 (7) 97 (12) 85 (8) 88 (10) 90 (2) 78 (5) 76(2) 
BuPB 7.54 7.8 97 (8) 79 (4) 85 (2) 84 (5) 88 (3) 82 (10) 103 (5) 95 (4) 106 (4) 
CBZ 6.22 4.6 98 (9) 84 (4) 89 (1) 91 (8) 89 (2) 85 (8) 78 (26) 89 (5) 84 (2) 
CFA 7.22 10.3 91 (14) 80 (7) 81 (2) 65 (9) 69 (5) 59 (8) 82 (8) 97 (8) 90 (5) 
DIC 8.57 9.6 90 (8) 83 (5) 89 (3) 86 (7) 87 (2) 84 (10) 104 (9) 93 (6) 104 (4) 
EtPB 5.64 7.6 87 (10) 71 (10) 79 (2) 82 (6) 82 (3) 78 (8) 99 (3) 95 (7) 106 84) 
IBU 8.77 6.8 100 (15) 84 (11) 99 (6) 87 (17) 88 (6) 89 (10) 90 (19) 108 (16) 108 (7) 
MePB 4.46 4.2 91 (10) 89 (4) 87 (2) 87 (9) 90 (3) 85 (10) 117 (7) 104 (9) 107 (3) 
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(1) Range of concentrations and average (in brackets) for the positive samples 665	
(2) Data only available for 6 out of 10 sampling stations included in the monitoring. The percentage of positives and average value correspond to the samples 666	
of those 6 sampling stations (Table 2SI for more detailed information) 667	
(3) n.a: data not available 668	






 04/2012 09/2012 10/2012 11/2012 02/2013 
%Positives Conc ng/L(1) %Positives Conc ng/L %Positives Conc ng/L %Positives Conc ng/L %Positives Conc ng/L 
BZP 100 9-100 (62)  62 8-243 (110) 53 84-385 (253)(2) n.a.(3) n.a n.a. n.a 
BZP-3 96 30-502 (238) 0  0  0  0  
BuPB 0  0  0  0  0  
CBZ 0  0  0  0  0  
CFA 0  0  0  0  0  
DIC 11 <LOQ(4) 0  0  3 <LOQ 0  
EtPB 4 <LOQ  0  0  0  0  
IBU 89 7-19 (11) 63 5-34 (10) 57 10-25(15) 100 7-62 (17) 100 7-58 (16) 
MePB 100 0-122 (38) 87 5-46 (22) 97 5-425(63) 87 6-39 (32) 100 22-265 (81) 
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Table 4. Concentrations (ng/L) of selected compounds in tributaries of reservoir RG 675	
 676	
 April 2012 November 2012 




E12 E15 E17 E19 QC  Rec (%) 
BZP 13 48 54 25 105 n.a.(2) n.a. n.a. n.a. n.a. 
BZP-3 98 66 162 - 81 - - - - 90 
BuPB - (3) <LOQ (4) - - 94 - - - - 78 
CBZ - - - - 90 - - - - 71 
CFA - - - - 87 - - - - 87 
DIC - - - - 108 - - - - 97 
EtPB - 29 - <LOQ 98 - - - - 91 
IBU 32 - <LOQ <LOQ 94 9 - <LOQ 12 94 
MePB <LOQ 242  10 17 99 29 23 14 58 95 
	677	
(1)   QC: Quality control. Rec (%): % recovery 678	
(2)   n.a.: data not available  679	
(3)   -: not detected 680	





















Table 5. Results of the monitoring in reservoir LF (data correspond to all samples collected at the different sites and at three depths) 700	
	701	
	702	
(1) Range of concentrations and average (in brackets) for the positive samples (Table 3SI for more detailed information) 703	
(2) n.a: data not available 704	








 06/2012 09/2012 10/2012 12/2012 02/2013 
%Positives Conc ng/L(1) %Positives Conc ng/L %Positives Conc ng/L %Positives Conc ng/L %Positives Conc ng/L 
BZP 55 5-143(57) 80 9-102 (40) 20 16-54 (34) n.a.(2) n.a. n.a. n.a 
BZP-3 0  0  0  0  0  
BuPB 10 8-16(12) 5 11 0  5 <LOQ(3) 10 18 
CBZ 0  0  0  0  0  
CFA 0  0  0  0  0  
DIC 0  0  0  0  0  
EtPB 55 8-50 (30) 0  5 8 5 59 10 18 
IBU 100 7-39 (12) 95 7-15 (11) 85 8-16 (11) 90 7-10 (8) 100 7-25 (12) 
MePB 100 21-276 (84) 15 11 (11) 100 3-57 (16) 40 6-49 (19) 100 8-113 (29) 
23	
	
Table 6. Concentrations (ng/L) of selected compounds in tributaries of reservoir LF 713	
 October 2012 December 2012 February 2013 
 E8 E9 E10 E11 
QC (1) 
Rec % E8 E9 E10 E11 
QC 
Rec % E8 E9 E10 E11 
QC  
Rec % 
BZP 71 - (3) 67 - 78 n.a. (2) n.a n.a n.a n.a. n.a. n.a n.a n.a n.a. 
BZP-3 - - - - 85 - - - - 75 - - - - 88 
BuPB - - - - 114 - - - - 88 - - - - 79 
CBZ - - - - 102 - - - - 77 - - - - 91 
CFA - - - - 112 - - - - 94 - - - - 109 
DIC - - - - 84 - - - - 114 - - - - 94 
EtPB - - - - 87 - - - - 81 - <LOQ - - 79 
IBU 10 - <LOQ (4) <LOQ 92 <LOQ - <LOQ <LOQ 94 20 - - 8 84 
MePB 5 6 6 - 104 10 14 17 13 112 24 57 25 34 110 
 714	
(1)   QC: Quality control. Rec (%): % recovery 715	
(2)   n.a.: data not available  716	
(3)   -: not detected 717	













(1) -: not detected 729	
(2) <LOQ: detected, concentration lower than the LOQ  730	
(3) QC: Quality control. Rec: % recovery 731	







BZP BZP3 BuPB CBZ CFA DIC EtPB IBU MePB 
September/12 Influent 101 30 12 -
(1) - - - 16 140 
Effluent 46 29 7 - - - - <LOQ(2) 80 
QC (%Rec) (3) 114 80 80 91 97 103 99 115 106 
October/12 Influent 103 11 - - - - - 14 27 
Effluent 33 7 - - - - - 14 21 
QC (%Rec) 73 108 67 74 119 90 120 110 127 
November/12 Influent n.a
(4). - - - - - - 15 69 
Effluent n.a. - - - - - - 8 29 
QC (%Rec) n.a. n.a. 87 94 124 122 119 110 114 
February/13 Influent n.a. - - - - 23 - 26 27 
Effluent n.a. - - - - 22 - 21 27 
QC (%Rec) n.a. n.a. 70 97 115 102 87 123 95 
La Ayurá (LA) 
  
 
BZP BZP3 BuPB CBZ CFA DIC EtPB IBU MePB 
September/12 Influent 
32 30 - - - 16 - 14 32 
Effluent 30 24 - - - <LOQ - 14 33 
QC (%Rec) 114 80 80 91 97 103 99 115 106 
October/12 Influent 
41 14 - - - 12 - 15 44 
Effluent 40 7 - - - - - 12 35 
QC (%Rec) 73 108 67 74 119 90 120 110 127 
December/12 Influent 
n.a. - - - - - - 11 34 
Effluent n.a. - - - - - - 12 34 
QC (%Rec) n.a. n.a. 87 94 124 122 119 110 114 
February/13 Influent 
n.a. - - - - - - 22 26 
Effluent n.a. - - - - - - 24 26 





Fig 1. Sampling sites at the reservoir RG. Numbers 12, 15, 17 and 19 correspond to tributaries 739	
Fig 2. Sampling sites at the reservoir LF. Numbers 8, 9, 10 and 11 correspond to tributaries 740	
Fig 3. LC-MS/MS chromatograms for the efluent water sample of the DWTP of Manantiales, collected in 741	
September 2012, showing positive findings of BZP (A) and MePB (B). Q/q ratios and deviations with 742	
respect to the reference standard are shown. 743	
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